Antibiotic exposure elicits the emergence of colistin- and carbapenem-resistant Escherichia coli coharboring MCR-1 and NDM-5 in a patient
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibiotic exposure elicits the emergence of colistin- and carbapenem-resistant Escherichia coli coharboring MCR-1 and NDM-5 in a patient
Authors
Keywords
-
Journal
Virulence
Volume 9, Issue 1, Pages 1001-1007
Publisher
Informa UK Limited
Online
2018-07-26
DOI
10.1080/21505594.2018.1486140
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery and characterisation of an escherichia coli ST206 strain producing NDM-5 and MCR-1 from a patient with acute diarrhoea in China
- (2018) Beiwen Zheng et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Mechanistic insights into transferable polymyxin resistance among gut bacteria
- (2018) Yongchang Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Towards Understanding MCR-like Colistin Resistance
- (2018) Jian Sun et al. TRENDS IN MICROBIOLOGY
- An Evolutionarily Conserved Mechanism for Intrinsic and Transferable Polymyxin Resistance
- (2018) Yongchang Xu et al. mBio
- Discovery of a mcr-1-bearing plasmid in commensal colistin-resistant Escherichia coli from healthy broilers in Faisalabad, Pakistan
- (2018) Jiali Lv et al. Virulence
- Defining ICR-Mo, an intrinsic colistin resistance determinant from Moraxella osloensis
- (2018) Wenhui Wei et al. PLoS Genetics
- Transferability of MCR-1/2 Polymyxin Resistance: Complex Dissemination and Genetic Mechanism
- (2018) Youjun Feng ACS Infectious Diseases
- Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1
- (2017) Yu-Feng Zhou et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding
- (2017) Anandhi Anandan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complete genome sequencing and genomic characterization of two Escherichia coli strains co-producing MCR-1 and NDM-1 from bloodstream infection
- (2017) Beiwen Zheng et al. Scientific Reports
- Coexistence ofmcr-1andblaNDM-1in Escherichia coli from Venezuela
- (2016) Jose F. Delgado-Blas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of NDM-5- and MCR-1-Producing Escherichia coli Clones ST648 and ST156 from a Single Muscovy Duck (Cairina moschata)
- (2016) Run-Shi Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coproduction of MCR-1 and NDM-1 by Colistin-Resistant Escherichia coli Isolated from a Healthy Individual
- (2016) Lan-Lan Zhong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coexistence of MCR-1 and NDM-1 in Clinical Escherichia coli Isolates: Table 1.
- (2016) Beiwen Zheng et al. CLINICAL INFECTIOUS DISEASES
- UN High-Level Meeting on antimicrobials—what do we need?
- (2016) Ramanan Laxminarayan et al. LANCET
- Dissemination of the mcr-1 colistin resistance gene
- (2016) Chanping Zhi et al. LANCET INFECTIOUS DISEASES
- Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
- (2016) Xu Yao et al. LANCET INFECTIOUS DISEASES
- Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
- (2016) Yi-Yun Liu et al. LANCET INFECTIOUS DISEASES
- Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and bla NDM-5 , Causing a Complicated Urinary Tract Infection in a Patient from the United States: TABLE 1
- (2016) José R. Mediavilla et al. mBio
- Dissemination and Mechanism for the MCR-1 Colistin Resistance
- (2016) Rongsui Gao et al. PLoS Pathogens
- Co-transfer of blaNDM-5 and mcr-1 by an IncX3–X4 hybrid plasmid in Escherichia coli
- (2016) Jian Sun et al. Nature Microbiology
- GenomeVx: simple web-based creation of editable circular chromosome maps
- (2008) G. C. Conant et al. BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started